Pouessel, Damien <br/><br/>
Targeted therapies in metastatic renal cell carcinoma: the light at the end of the tunnel.  [electronic resource] 

 -  Expert review of anticancer therapy  Dec 2006 
 - 1761-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-8328 
<br/><br/><label>Standard No.: </label>10.1586/14737140.6.12.1761  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--therapeutic use<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Agents--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Benzenesulfonates--therapeutic use<br/>Bevacizumab<br/>Carcinoma, Renal Cell--drug therapy<br/>Chemotherapy, Adjuvant<br/>Drug Delivery Systems<br/>Drug Therapy, Combination<br/>Forecasting<br/>Humans<br/>Immunologic Factors--therapeutic use<br/>Immunotherapy<br/>Indoles--therapeutic use<br/>Interferon-alpha--administration & dosage<br/>Interleukin-2--administration & dosage<br/>Kidney Neoplasms--therapy<br/>Neoplasm Proteins--antagonists & inhibitors<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds<br/>Protein Kinase Inhibitors--therapeutic use<br/>Protein Kinases--drug effects<br/>Pyridines--therapeutic use<br/>Pyrroles--therapeutic use<br/>Receptors, Vascular Endothelial Growth Factor--antagonists & inhibitors<br/>Sirolimus--analogs & derivatives<br/>Sorafenib<br/>Sunitinib<br/>TOR Serine-Threonine Kinases